Fairmount Funds Management LLC
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1802528
WEST CONSHOHOCKEN, PA
Position in DNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$212,921,068
+$124,847,427 QoQ
Shares Held
2,537,191
+18.7% QoQ
Ownership
4.64%
of shares outstanding
% of Portfolio
15.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fairmount Funds Management LLC holds $1,384,339,426 across 12 Biotechnology names. DNTH ranks #2 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMRA |
Damora Therapeutics, Inc.
|
8,713,000 | $225,666,700 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
2,537,191 | $212,921,068 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
5,503,418 | $211,826,558 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
4,018,101 | $202,673,014 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
3,705,262 | $181,743,101 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
3,914,458 | $76,566,798 | |
| 7 | ELVN |
Enliven Therapeutics, Inc.
|
1,855,644 | $72,741,244 | |
| 8 | JBIO |
Jade Biosciences, Inc.
|
4,553,494 | $63,976,590 |
All Filings in DNTH
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $212,921,068 | 2,537,191 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,073,641 | 2,137,191 | Shares | Sole | 2026-02-17 | |
| 2025-11-21 | $88,687,870 | 2,139,635 | Shares | Sole | 2025-11-25 | |
| 2025-09-30 | $130,137,965 | 3,307,191 | Shares | Sole | 2025-11-14 | |
| 2025-09-11 | $153,410,688 | 4,052,052 | Shares | Sole | 2025-09-15 | |
| 2025-06-30 | $50,434,968 | 2,707,191 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,990,534 | 2,700,691 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $58,875,063 | 2,700,691 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $73,944,919 | 2,700,691 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $71,502,221 | 2,762,837 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $82,885,110 | 2,762,837 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,056,431 | 1,928,503 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,362,636 | 1,928,503 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||